EndoTODAY | EndoATLAS | Outpatient Clinic
Parasite | Esophagus | Stomach | Cancer | ESD
Home | Guide | Author | Search | Blog | Links
[´ëÇÑ»óºÎÀ§Àå°üÇ︮ÄÚ¹ÚÅÍÇÐȸ ¿öÅ©¼¥]
ÀϽà - 2017³â 9¿ù 1ÀÏ (±Ý) - 9¿ù 2ÀÏ (Åä)
Àå¼Ò - ¾çÆò ºí·ëºñ½ºÅ¸È£ÅÚ ¾Æ»êȦ
1) Human microbiome: current concept and its application. ÇѾçÀÇ´ë ±èÁ¤¸ñ
2) The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. °¡Å縯ÀÇ´ë ½Ã½ºÅÛÀÇÇבּ¸¼¾ÅÍ ±èµ¿Çö ¹Ú»ç
3) Longterm PPI use and gut microbiota. ¼¿ïÀÇ´ë Á¤Çö¼ö
PPIÀÇ pH ¹«°ü È¿°ú: (1) Hormonal effect, (2) Nutriant absoprtion, (3) Non-gastric H1/K1 ATPase (Vesper BJ. Current Drug Metab 2009)
Hp (+) ȯÀÚÀÇ À§³» micribiomeÀÇ 70-97%°¡ HelicobacterÀÓ. Helicobacter °ø»ý±Õµµ À§Á¾¾ç¹ß»ý¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ´Ù.
PPI »ç¿ëÀÚ¿¡¼ oral microbiota°¡ Áõ°¡µÇ¾î ÀÖ´Ù.
PPI »ç¿ëÀÚ º¯¿¡¼ Methylobacteriaceae°¡ ÇöÀúÇÏ°Ô °¨¼ÒµÇ¾î ÀÖ´Ù.
1) Á¡¸·ÇÏ Á¶±âÀ§¾ÏÀÇ ¸²ÇÁÀý ÀüÀÌ ¿¹Ãø ¸ðÇü ±¸ÃàÀ» ÅëÇÑ ³»½Ã°æÀýÁ¦ °¡À̵å¶óÀÎ ¿Ï¼º (¿¬¼¼´ëÇб³ ±èÁöÇö)
ÀϹÝÀûÀÎ ¹æ¹ý°ú ¸¶Âù°¡Áö·Î angleÀ» middle third·Î ºÐ·ùÇÏ¿´½À´Ï´Ù.
Comparison of criteria for endoscopic resection of submucosal invasive early gastric cancer with differentiated histology (2017-9-2. ±èÁöÇö) Criteria LNM incidence 95% CI Tumor less than 3 cm, submucosal invasion depth less than 500 um, no lymphovascular invasion, no perineural invasion 6/218(2.7%) 1.3-5.9 Tumor less than 3 cm, submucosal invasion depth less than 1,000um by alternative method, no lymphovascular invasion, no perineural invasion, submucosal invasion width less than 4mm 0/254(0%) 0-1.5
* Á¤ÈÆ¿ë ±³¼ö´Ô comment: depth of invasion°ú SM invasion width¸¦ µû·Î »ìÇǼ̴µ¥¿ä, ±× ºñÀ²À» ºÐ¼®ÇÏ¸é ´õ ÁÁÀ» °Í °°½À´Ï´Ù.
* ÀÌÁØÇà È¥À㸻:
ÇöÀç´Â SM 500 um±îÁö expanded criteria¿¡ ÀÇÇÑ º´¸®ÇÐÀû ¿ÏÀüÀýÁ¦·Î ÆÇ´ÜÇÏ°í Àִµ¥¿ä... ÀÌ ±âÁØ¿¡ ÇØ´çÇϴ ȯÀÚ Áß extragastric metastasis¸¦ º¸ÀÎ Áõ·ÊµéÀÌ °è¼Ó º¸°íµÇ°í ÀÖ¾î¼ 500 um¸¦ 300um ȤÀº ±× ÀÌÇÏ·Î ÁÙ¿©¾ß ÇÑ´Ù´Â ÁÖÀåµµ ÀÖ½À´Ï´Ù. À̹ø ±èÁöÇö ±³¼ö´ÔÀÇ ºÐ¼®¿¡ ÀÇÇϸé SM invasion width°¡ 4mm·Î ¸Å¿ì ÀÛ´Ù¸é 1,000 um±îÁöµµ ¹®Á¦°¡ ¾øÀ» ¼ö ÀÖ´Ù´Â, Áï ¾ö¹ÐÇÑ Á¶°ÇÀ» ¸¸Á·Çϸé SM invasion ±âÁØÀ» ±âÁ¸À» 500 um¿¡¼ 1,000 um±îÁö È®ÀåÇÒ ¼ö ÀÖ°Ú´Ù´Â °á·ÐÀÔ´Ï´Ù. Áï SM invasion cancerÀÇ º´¸®ÇÐÀû ¿ÏÀüÀýÁ¦ ±âÁØÀ» ÀϺδ ³ÐÈ÷°í ÀϺδ Á¼Çô¾ß ÇÑ´Ù´Â ÁÖÀå °°½À´Ï´Ù.
±Ý¹ø ±èÁöÇö ±³¼ö´Ô ÀÚ·á¿¡¼ lymphovascular invasionÀÇ ºñÀ²Àº 31.0% (558/1,798)·Î »ó´çÈ÷ ³ô¾Ò½À´Ï´Ù. Dedicated GI pathology specialist°¡ ÀÚ¼¼È÷ ºÐ¼®ÇÑ °á°ú¿´±â ¶§¹®À¸·Î »ý°¢µË´Ï´Ù. Original pathology report¿¡¼ LVI ºÐ¼®°ú ±Ý¹ø dedicated GI pathology specialist¿¡ ÀÇÇÑ ÀçÆò°¡ÀÇ °á°ú Â÷ÀÌ°¡ ¾î´À Á¤µµ¿´´ÂÁö ºÐ¼®Çغ¸¸é Èï¹Ì·Î¿ï °Í °°½À´Ï´Ù.
¾Æ·¡´Â 2017³â 8¿ù 27ÀÏ ³»½Ã°æ ¼¼¹Ì³ª¿¡¼ ¹Îº´ÈÆ ±³¼ö´Ô²²¼ º¸¿©ÁֽŠ¼¼ ÀåÀÇ ½½¶óÀ̵åÀÔ´Ï´Ù. ºÐÈÇü Á¶±âÀ§¾Ï, 500 um ÀÌÇÏÀÇ SM1 cancerµµ Àç¹ßÀ§ÇèÀÌ ÀÖÀ¸¹Ç·Î, ÇöÀçÀÇ expanded criteria¸¦ Á¶±Ý Ãà¼ÒÇØ¾ß ÇÏÁö ¾ÊÀ»±î »ý°¢µÈ´Ù´Â ÁÖÀåÀ̾ú½À´Ï´Ù.
(1) Depth of invasion ÃøÁ¤ ±âÁØÀÌ ºÒ¸íÈ®ÇÕ´Ï´Ù.
(2) Surgical case¿¡¼ expanded criteria¿¡ ÇØ´çÇϴ ȯÀÚÀÇ ¸²ÇÁÀý ÀüÀÌ°¡ È®ÀεǾú½À´Ï´Ù.
Expanded criteria¿¡ ÇØ´çÇϴ ȯÀÚ°¡ extragastric recurrence¸¦ º¸À̸é Ä¡·á¸¦ ´ã´çÇÏ¿´´ø ÀÇ»çÀÇ °¡½¿Àº Âõ¾îÁý´Ï´Ù. ±×·¯ÇÑ È¯ÀÚ¸¦ °æÇèÇÑ ¹Ù ÀÖ´Â ESD ½Ã¼úÀÚ ÀÔÀå¿¡¼ Àú´Â 500umµµ ºÎ´ãÀε¥, trickyÇÑ Á¶°ÇÀ» ºÙ¿©¼ 1,000um·Î ³ÐÈ÷´Â °ÍÀº ³Ê¹«³Ê¹« ºÎ´ã½º·´½À´Ï´Ù.
Çмú ¸ðÀÓ¿¡¼´Â Æò¼Ò¿¡ ¸¸³ªºË±â ¾î·Á¿î °¢ º´¿øÀÇ °í¼öµé°ú ´ëȸ¦ ³ª´©¸é¼ ´À³¢°í ¹è¿ì´Â °ÍÀÌ ¸¹½À´Ï´Ù. À̹ø¿¡´Â fellow training program¿¡ ´ëÇÑ ´ëȸ¦ ³ª´ ±âȸ°¡ ÀÖ¾ú½À´Ï´Ù.
A ±³¼ö´Ô comment:
"Fellow program¿¡¼ ³»½Ã°æ ½Ã¼úÀÌ Â÷ÁöÇÏ´Â ºñÀ²ÀÌ ³Ê¹« ³ô½À´Ï´Ù. ÀÌ·± »óȲÀ̶ó¸é ³»°úÀÇ»ç·Î¼ ³»½Ã°æÀ» ÀûÀýÈ÷ È°¿ëÇÏ¿© ȯÀÚ¸¦ Áø´ÜÇÏ°í Ä¡·áÇÏ´Â °ÍÀ» ¹è¿ì´Â °ÍÀÌ ¾Æ´Ï¶ó ³»½Ã°æ ±â¼úÀÚ°¡ µÇ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. ÀÀ±Þ½Ç°ú º´½Ç ȯÀÚ Áø·á¿¡ Á» ´õ ¸¹Àº ½Ã°£À» È°¿ëÇØ¾ß ÇÕ´Ï´Ù."
ÀÌÁØÇàÀÇ ÀÀ´ä:
"Fellow ÈƷñⰣÀº ±æ¾î¾ß 1-2³âÀÔ´Ï´Ù. ±× ±â°£ µ¿¾È °©ÀÚ±â ÈǸ¢ÇÑ ³»°ú Àǻ縦 ¸¸µé ¼ö ¾ø½À´Ï´Ù. ÀÀ±Þ½Ç°ú º´½Ç ȯÀÚ Áø·áµµ Áß¿äÇÏÁö¸¸, fellow µéÀÌ ¹«¾ùÀ» ¿øÇÏ´ÂÁö¸¦ ¹Ý¿µÇÑ ÇÁ·Î±×·¥ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ´ëºÎºÐÀÇ ¼Òȱâ fellow 1³âÂ÷ ¼±»ý´ÔµéÀº ³»½Ã°æÀ» Àß ¹è¿ì´Â °ÍÀ» ¿øÇÏ°í ÀÖ½À´Ï´Ù. ªÀº ½Ã°£ µ¿¾È È¿°úÀûÀ¸·Î ³»½Ã°æÀ» ¹è¿ï ¼ö ÀÖ´Â ÇÁ·Î±×·¥À» Á¦°øÇÏ´Â °ÍÀÌ ¹«¾ùº¸´Ù ¼±ÇàµÇ¾î¾ß ÇÒ °Í °°½À´Ï´Ù. ³»°ú ÀÇ»ç·Î¼ÀÇ Åµµ¸¦ °¡¸£ÃÄ¾ß ÇÑ´Ù´Â ÀÌÀ¯·Î ³»½Ã°æ ±³À°ÀÇ ºñÁßÀ» ³·°Ô Çϱâ´Â ¾î·ÆÁö ¾ÊÀ»±î¿ä?"
B ±³¼ö´Ô comment:
"Fellow µéÀº ÀÌ¹Ì ¼ºÀÎÀÔ´Ï´Ù. º´¿ø¿¡¼ ¾î¶² ÇÁ·Î±×·¥À» ¿î¿µÇÏ°í ÀÖ´ÂÁö, ÀÏÁÖÀÏ¿¡ ¸î ½Ã°£ Á¤µµ ÀÏÇÏ°í ÀÖ´ÂÁö ´Ù ¾Ë°í ÀÖ´Â »óÅ¿¡¼ ½º½º·ÎÀÇ ¼±Åÿ¡ ÀÇÇÏ¿© º´¿ø¿¡¼ ÀÏÇÏ°Ô µÈ °ÍÀÔ´Ï´Ù. ¹Ì±¹ fellow µéÀÌ ÀÏÁÖÀÏ¿¡ ¸î ½Ã°£ ÀÏÇÏ´ÂÁö ¾Ë°í °è½Ê´Ï±î? ¿µ±¹¿¡¼ ÀÇ»çµéÀÌ Æľ÷ÇÑ ÀÌÀ¯ Áß Çϳª°¡ ±Ù¹«½Ã°£ÀÌ ³Ê¹« ª¾Æ Á¦´ë·Î µÈ trainingÀ» ¹ÞÁö ¸øÇÏ¿© training ±â°£ÀÌ ±æ´Ù¸ç ÁÖ ´ç ±Ù¹«½Ã°£À» ´Ã·Á´Þ¶ó´Â °ÍÀ̾ú´Ù´Â °ÍÀ» ¾Ë°í ÀÖ½À´Ï±î? "
ÀÌÁØÇàÀÇ ÀÀ´ä:
"FellowµéÀº °í°´À̶ó°í »ý°¢ÇÕ´Ï´Ù. ÇDZ³À°ÀÚÀÔ´Ï´Ù. ±×µé¿¡°Ô ÀûÀýÇÑ Á¤µµÀÇ ±³À°±âȸ¿Í ÈÞ½ÄÀ» Á¦°øÇØ¾ß ÇÕ´Ï´Ù. ÀϺΠ¹Ì±¹ fellowµéÀÌ ¾öû³ª°Ô ±ä ½Ã°£ ±Ù¹«ÇÏ´Â °ÍÀº Àß ¾Ë°í ÀÖÀ¸³ª, ÀÌ´Â ¿¹¿ÜÀÏ »Ó º¸ÆíÀûÀ¸·Î Àû¿ëÇÒ ¼ö ÀÖ´Â ¸ðµ¨Àº ¾Æ´Ò °ÍÀÔ´Ï´Ù. ¾î´À Á÷Á¾À̳ª ¾öû³ª°Ô ¸¹Àº ÀÏÀ» ÇÏ´Â ÀϺΠ»ç¶÷Àº Àֱ⠸¶·ÃÀÔ´Ï´Ù. ÀڱⰡ ¸ñÀûÇÏ´Â ¹Ù ÀÖ¾î ¸¹Àº ³ë·ÂÀ» ÇÏ´Â °ÍÀ» ¸·À» ¼ö ¾ø°ÚÁö¸¸, À̸¦ Ç¥ÁØÀûÀÎ ÇÁ·Î±×·¥À¸·Î ¸¸µé ¼ö ¾ø½À´Ï´Ù. °Ô´Ù°¡ ÇöÀç Àü°øÀǵéÀÌ ÁÖ 80½Ã°£ Á¦µµ¿¡¼ ÀÏÇÏ°í ÀÖ½À´Ï´Ù. '80½Ã°£ Àü°øÀÇ'µéÀÌ fellow°¡ µÇ´Â 2³â ÈÄ¿¡´Â '80½Ã°£ fellow'°¡ new normalÀÌ µÉ °ÍÀÔ´Ï´Ù. ÇöÀçÀÇ fellow training programÀº Áö¼Ó°¡´ÉÇÑ ¸ðµ¨ÀÌ ¾Æ´Õ´Ï´Ù. °ÅÄ£ ÃßÃøÀÔ´Ï´Ù¸¸.... ÇöÀ纸´Ù 30% Á¤µµ´Â ¾÷¹«·®À» ÁÙ¾îÁÖ¾î¾ß ÇÒ °Í °°½À´Ï´Ù. ¾î¶»°ÔÇϸé fellowµéÀÇ ¾÷¹«·®À» ÁÙÀÏ °ÍÀΰ¡ °í¹ÎÇÒ ½ÃÁ¡ÀÔ´Ï´Ù. º´¿øÀÇ Àü¹ÝÀûÀÎ down-sizingÀÌ ÇÊ¿äÇÕ´Ï´Ù."
1) ´ëÇÑ»óºÎÀ§Àå°üÇ︮ÄÚ¹ÚÅÍÇÐȸ ÇмúÇà»ç Áö»óÁß°è
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.